Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
NCT01219751
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG:
Sunitinib
Sponsor
Asan Medical Center
Collaborators
[object Object]
[object Object]
[object Object]